Ireland’s Data Protection Commission Launches GDPR Investigation Into X’s AI Chatbot Grok 
Santos Wins Court Case Over Net Zero and Sustainability Claims 
Medical Groups Sue FTC Over Gender-Affirming Care Investigations Amid Trump Policy Dispute 
Qualcomm to Invest $150 Million in India AI Startups, Strengthening Presence in Growing Market 
European IT Hardware Stocks to Watch as Gaming Demand Outpaces Smartphones, Says BofA 
Anderson Cooper to Exit CBS News’ 60 Minutes After Nearly 20 Years 
Stock Market Movers: NVIDIA and Meta Expand AI Partnership as Cadence Surges on Earnings 
Starboard Value Targets Tripadvisor Board Overhaul Amid Stock Slump 
Thomas Pritzker to Step Down as Hyatt Executive Chairman After Epstein Ties Acknowledged 
Treasury Wine Estates Profit Falls 46% as China and U.S. Inventory Reset Weighs on Earnings 
Anduril Industries Seeks $8 Billion Funding at $60 Billion Valuation 
Freedom Finance and Binance Join Forces in Digital Assets 
Mitsui Kinzoku Stock Surges to Record High After Profit Forecast Upgrade and Dividend Increase 
India AI Impact Summit 2026: Global Tech CEOs Join World Leaders in New Delhi 
NAB Shares Hit Record High as First-Quarter Cash Earnings Jump 16% 
Waymo Clarifies Role of Remote Workers Amid U.S. Robotaxi Safety Scrutiny 
Macquarie-Led Consortium to Acquire Qube Holdings in A$11.7 Billion Deal 
WALTHAM, Mass., May 01, 2018 -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences are:
- The Bank of America Merrill Lynch 2018 Healthcare Conference at the Encore Hotel in Las Vegas, Nevada on Tuesday, May 15, 2018. Tim Pearson, EVP and CFO of TESARO, will participate in an analyst-led moderated Q&A at 4:20 PM PT and in meetings with investors.
- The Leerink Boston Biopharma Bus Tour on Thursday, May 17, 2018. Lonnie Moulder, CEO, and Mary Lynne Hedley, Ph.D., President and COO of TESARO, will present at 1:00 PM ET and will answer questions from investors.
A live webcast of the presentation at the Bank of America conference will be available by visiting the Investors section of the TESARO website at www.tesarobio.com. An archived replay of this webcast will be available on the Company’s website for 14 days following the conferences.
About TESARO
TESARO is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients by acquiring, developing and commercializing safer and more effective therapeutics. For more information, visit www.tesarobio.com, and follow us on Twitter and LinkedIn.
For additional information, please contact:
Jennifer Davis
Vice President, Corporate Communications and Investor Relations
+1.781.325.1116 or [email protected]
Kate Rausch
Associate Director, Investor Relations
1.781-257-2505 or [email protected]
